Control of HIV-1 RNA load after HAART interruption: Relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients

Journal of Clinical Virology

Volumn 40, Issue 1, 2007, Pages 64-67

  Soriano Sarabia, Natalia ^a   Vallejo, Alejandro ^a   Fernández, Gerónimo ^b   Genebat, Miguel ^a   Gutiérrez, Sonia ^a   Muñoz Fernández, Maria Ángeles ^b   Leal, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

CCR5 density; HAART interruption; HIV controllers; Proviral DNA load

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; RNA ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROVIRUSES; RECEPTORS, CCR5; VIRAL LOAD;

EID: 34548129579     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.06.010     Document Type: Article

References (18)

1. Betts M., Krowka J., Kepler T.B., Davidian M., Christopherson C., Kwok S., et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses 15 (1999) 1219-1228
2. Costantini A., Mancini S., Giuliodoro S., Butini L., Regnery C.M., Silvestri G., et al. Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278 (2003) 145-155
3. Deeks S.G., Martin J.N., Sinclair E., Harris J., Neilands T.B., Maecker H.T., et al. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis 189 (2004) 312-321
4. Emu B., Sinclair E., Favre D., Moretto W.J., Hsue P., Hoh R., et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 79 (2005) 14169-14178
5. Fernandez G, Muñoz-Fernández MA. patent 200, 401, 986. Spain; 2005.
6. Finzi D., Hermankova M., Pierson T., Carrut L.M., Buck C., Chaisson R.E., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 (1997) 1295-1300
7. Gibellini D., Vitone F., Schiavone P., Ponti C., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 29 (2004) 282-289
8. ® Real-time PCR. BMC Infect Dis 5 (2005) 15-24
9. Kostrikis L.G., et al., Multicenter Hemophilia Cohort Study Group. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 76 (2002) 10099-10108
10. Lafeuillade A., Poggi C., Hittinger G., Counillon E., and Emilie D. Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies. J Infect Dis 188 (2003) 1426-1432
11. Lambotte O., et al., Seroco-Hemoco Study Group. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis 41 (2005) 1053-1056
12. Madeca Y., Boufassaa F., Porterb K., and Meyera L. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 19 (2005) 2001-2007
13. Pantaleo G.S., and Koup R.A. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10 (2004) 806-810
14. Reynes J., Baillat V., Portales P., Clot J., and Corbeau P. Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy. JAMA 291 (2004) L46
15. Reynes J., Portales P., Segondy M., Baillat V., Andre P., Reant B., et al. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis 181 (2000) 927-932
16. Vallejo A., Valladares A., de Felipe B., Vivancos J., Gutierrez S., Soriano-Sarabia N., et al. High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection. Viral Immunol 18 (2005) 740-746
17. Vincent T., Portales P., Baillat V., Eden A., Clot J., Reynes J., et al. The immunological response to highly active antiretroviral therapy is linked to CD4+ T-cell surface CCR5 density. J Acquir Immune Defic Syndr 43 (2006) 377-378
18. Weissman D., Dybul M., Daucher M.B., Davey Jr. R.T., Walker R.B., and Kovacs J.A. Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4 lymphocytes in vivo. J Infect Dis 181 (2000) 933-938